Article
Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime.
Antimicrobial agents and chemotherapy - 1 Jun 2002
Vakulenko Sergei B, Golemi Dasantila, Geryk Bruce, Suvorov Maxim, Knox James R, Mobashery Shahriar, Lerner Stephen A
Abstract excerpt
The class C beta-lactamase from Enterobacter cloacae P99 confers resistance to a wide range of broad-spectrum beta-lactams but not to the newer cephalosporin cefepime. Using PCR mutagenesis of the E. cloacae P99 ampC gene, we obtained a Leu-293-Pro mutant of the P99 beta-lactamase conferring a hi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
